Mutation Clearance after Transplantation for Myelodysplastic Syndrome

BACKGROUND: Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for patients with myelodysplastic syndrome (MDS). The molecular predictors of disease progression after transplantation are unclear. METHODS: We sequenced bone marrow and skin samples from 90 adults with MD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Duncavage, Eric J., Jacoby, Meagan A., Chang, Gue Su, Miller, Christopher A., Edwin, Natasha, Shao, Jin, Elliott, Kevin, Robinson, Joshua, Abel, Haley, Fulton, Robert S., Fronick, Catrina C., O’Laughlin, Michelle, Heath, Sharon E., Brendel, Kimberly, Saba, Raya, Wartman, Lukas D., Christopher, Matthew J., Pusic, Iskra, Welch, John S., Uy, Geoffrey L., Link, Daniel C., DiPersio, John F., Westervelt, Peter, Ley, Timothy J., Trinkaus, Kathryn, Graubert, Timothy A., Walter, Matthew J.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309244/
https://ncbi.nlm.nih.gov/pubmed/30207916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1804714
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars